Skip to main navigation Skip to search Skip to main content

Battling COVID-19: Using old weapons for a new enemy

  • Rohit Kumar
  • , Nitin Gupta
  • , Parul Kodan
  • , Ankit Mittal
  • , Manish Soneja*
  • , Naveet Wig
  • *Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Coronavirus disease-19 (COVID-19) has reached pandemic proportions. Most of the drugs that are being tried for the treatment have not been evaluated in any randomized controlled trials. The purpose of this review was to summarize the in-vitro and in-vivo efficacy of these drugs on Severe Acute Respiratory Syndrome (SARS-CoV-2) and related viruses (SARS and Middle East Respiratory Syndrome) and evaluate their potential for re-purposing them in the management of COVID-19.

Original languageEnglish
Article number6
JournalTropical Diseases, Travel Medicine and Vaccines
Volume6
Issue number1
DOIs
Publication statusPublished - 20-05-2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Battling COVID-19: Using old weapons for a new enemy'. Together they form a unique fingerprint.

Cite this